Le Lézard
Classified in: Health, Science and technology, Business
Subjects: ASI, CXP

Yisheng Biopharma Announces Opening of New Business Divisions in Cambodia, Expanding Presence within Southeast Asia


BEIJING, July 19, 2018 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, today announced the grand opening of Anderson Biotech Company Limited and Royal OncoCare Hospitality as two wholly owned subsidiaries of Yisheng Biopharma in Cambodia. The two divisions represent the first expansion of Yisheng Biopharma business and product sales operations into an ASEAN member country.

"The opening of these two divisions is an important milestone in company history," commented Zhang Yi, Founder and Chairman of Yisheng Biopharma. "Our product YivykaTM is approved in Cambodia for the treatment of advanced solid tumors, including lung, breast, liver, colorectal and stomach cancers. We are pleased to be in a position to expand access to the benefits that this product will bring to cancer patients and are grateful for the support we have received from the Ministry of Health of the Kingdom of Cambodia."

"ASEAN countries have witnessed a significant economic boom over the last decade and represent one of the fastest growing markets for the biopharmaceutical industry," added David Shao, Ph.D., President and CEO of Yisheng Biopharma. "With a population of over 600 million under-served individuals in these countries, we are committed to expanding and deepening our presence in this region of southeast Asia. We are conducting drug development in this region, with programs in immuno-oncology, rabies and hepatitis B infection, and are well positioned to introduce a series of innovative products into this region."

YivykaTM is an innovative immuno-oncology drug recently granted a drug registration license by the Ministry of Health of the Kingdom of Cambodia. YivykaTM is the first biological product introduced into the Cambodia market by Yisheng Biopharma. 

About Yisheng Biopharma Co., Ltd.

Yisheng Biopharma is a global biopharmaceutical company discovering, developing and commercializing innovative immunological biologics. With approximately 700 employees worldwide and operations in China, the United States, Singapore and certain Southeast Asian countries. 

www.yishengbio.com

 

SOURCE Yisheng Biopharma Co., Ltd.


These press releases may also interest you

at 09:40
Evocative Partners with Megaport to Expand Cloud Connectivity
Evocative, a global provider of Internet infrastructure, today announces its partnership with Megaport, a leading cloud interconnectivity service provider. This joint initiative expands Evocative's open digital ecosystem with an additional 300+...

at 09:35
Wolters Kluwer report: unified and proactive care that addresses social drivers of health can help reduce cardiovascular disease
Wolters Kluwer Health has released a new report outlining how healthcare leaders can help drive better patient outcomes for cardiovascular health. A whole, strategic approach to wellness spanning the entire care journey is cited as vital. The report,...

at 09:35
HG Insights Delivers Real-Time Analysis with Market Intelligence
HG Insights, the authority in Technology Intelligence, today announced the launch of its new Market Intelligence product, a platform providing the data and insights that strategists and marketers need to scope the size and shape of new and existing...

at 09:34
Neonode Reports Quarter Ended March 31, 2024 Financial Results
Neonode Inc. ("Neonode" or the "Company") today reported financial results for the three months ended March 31, 2024. FINANCIAL SUMMARY FOR THE QUARTER ENDED MARCH 31, 2024:       Revenue of $1.0 million, a decrease of 19.1% compared to the same...

at 09:30
Valmet chosen as the third most attractive employer by engineering students in Finland
Valmet has been chosen as the third most attractive employer by engineering students in Finland. The ranking was published in Universum's annual Talent Research, which is the biggest employer survey in Finland. Valmet has kept its position as one of...

at 09:30
Indusface Becomes the Only Vendor to be Recognized as Global Customer' Choice with 100% Customer Recommendation for Three Consecutive Years
Indusface, a leading application security SaaS company trusted by over 5000 customers across 95 countries, today announced that it has been named as 2024 Gartner® Peer Insightstm Customers' Choice for Cloud Web Application and API Protection (WAAP)...

More news about Science and technology...


News published on and distributed by: